Stockreport

Gilead in charts: Revenue from liver disease product sees highest Y/Y rise of 17% [Seeking Alpha]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF Gilead Sciences: Buy This Stock For Both Dividend And Growth Gilead Sciences: Margin Expansion And Cash Flow Strength Underpriced Gilead: A Top GARP Biotech Play, B [Read more]